An early paper from Sethi et al. used multiplex ligation-dependent probe amplification (MLPA) to study copy numbers of a panel of genes and found that amplification of two genes (PMAIP1 and PTPN1) could differentiate HNSCC patients from normal controls [30]. This evidence concerns the gene PMAIP1 and head and neck squamous cell carcinoma.